# Veeva Systems Inc. – Consensus ‘buy’ rating and 16.6% Upside Potential - Link: https://www.directorstalkinterviews.com/veeva-systems-inc.consensus-buy-rating-and-16.6-upside-potential/4121132332 - Published: 2023-11-09T12:29:20+00:00 - Author: Charlotte Edwards **Veeva Systems Inc.** with ticker code (VEEV) now have 22 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $265.00 and $181.00 and has a mean target at $226.27. Now with the previous closing price of $194.12 this indicates there is a potential upside of 16.6%. The day 50 moving average is $204.93 and the 200 day moving average is $188.79. The company has a market capitalization of 31.19B. The stock price is currently at: $194.13 USD The potential market cap would be $36,353,506,913 based on the market consensus. The company is not paying dividends at this time. Other points of data to note are a P/E ratio of 58.47, revenue per share of $14.12 and a 5.3% return on assets. Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry. The Company’s offerings span cloud software, data, and business consulting and are designed to meet the needs of its customers and their most strategic business functions from research and development (R&D) to commercialization. The Company’s industry cloud solutions for the life sciences industry are grouped into two major product families: Veeva Development Cloud and Veeva Commercial Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its proprietary Veeva Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical affairs, and marketing functions of a life sciences company. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass. Share on: